BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published online September 3, 2007
British Journal of Radiology (2007) 80, 855-858
© 2007 British Institute of Radiology
doi: 10.1259/bjr/29504942

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ledingham, K W D
Right arrow Articles by Sauerbrey, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledingham, K W D
Right arrow Articles by Sauerbrey, R

Commentary

Laser-driven proton oncology — a unique new cancer therapy?

K W D Ledingham, DSC 1,3 W Galster, PhD 1 and R Sauerbrey, PhD 2

1 SUPA, Department of Physics, University of Strathclyde, Glasgow G4 0NG, Scotland, 2 Forschungszentrum, Dresden Rossendorf, Germany, 3 AWE plc, Aldermaston, Reading RG7 4PR, UK

Correspondence: Dr Wilfried Galster, Department of Physics, University of Strathclyde, 107 Rottenrow East, Glasgow G4 0NG, Scotland. E-mail: wilfred.galster{at}strath.ac.uk

In 2000, the University of Strathclyde, collaborating with the Rutherford Appleton Laboratory, organized the first workshop dealing with the potential of high-power laser technology in medicine. Two areas of potential were identified: firstly the production of positron emission tomography (PET) isotopes; and secondly, the potential for laser-accelerated proton and heavy ion beams for therapy. The attendees, mainly clinicians and radiation physicists, emphasised that the laser community should concentrate on developing laser and target technology for therapy rather than isotope production because of the potential advantages over conventional accelerator technology for that purpose. On the 30 March 2007, the universities of Strathclyde and Paisley organized a follow-up meeting to identify the progress made in laser-driven proton and ion beam technology with applications leading to proton and ion beam therapy for deep-seated tumours. The meeting was supported by the Scottish Universities Physics Alliance (SUPA) — an organization set up in Scotland to bring together all of the physics departments collaborating with life scientists to work on ground-breaking new science which no single university could attempt. This is a summary of the meeting.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2007 by the British Institute of Radiology.